Ignite Creation Date:
2025-12-24 @ 12:40 PM
Ignite Modification Date:
2025-12-25 @ 12:12 PM
Study NCT ID:
NCT00960661
Status:
COMPLETED
Last Update Posted:
2015-04-07
First Post:
2009-08-17
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2012-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-08-17
First Submit QC Date:
None
Study First Post Date:
2009-08-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-09-05
Results First Submit QC Date:
None
Results First Post Date:
2013-12-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-19
Last Update Post Date:
2015-04-07
Last Update Post Date Type:
ESTIMATED